Barclays’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.06M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | $603K | Buy |
|
|||||
|
2022
Q3 | $348K | Sell |
|
|||||
|
2022
Q2 | $475K | Sell |
|
|||||
|
2022
Q1 | $948K | Sell |
|
|||||
|
2021
Q4 | $1.61M | Buy |
|
|||||
|
2021
Q3 | $2.58M | Buy |
|
|||||
|
2021
Q2 | $693K | Sell |
|
|||||
|
2021
Q1 | $784K | Buy |
|
|||||
|
2020
Q4 | $252K | Sell |
|
|||||
|
2020
Q3 | $229K | Sell |
|
|||||
|
2020
Q2 | $3.11M | Sell |
|
|||||
|
2020
Q1 | $4.56M | Sell |
|
|||||
|
2019
Q4 | $7.03M | Buy |
|
|||||
|
2019
Q3 | $796K | Sell |
|
|||||
|
2019
Q2 | $1.22M | Sell |
|
|||||
|
2019
Q1 | $1.18M | Buy |
|
|||||
|
2018
Q4 | $537K | Buy |
|
|||||
|
2018
Q3 | $578K | Buy |
|
|||||
|
2018
Q2 | $41K | Sell |
|
|||||
|
2018
Q1 | $87K | Buy |
|
|||||
|
2017
Q4 | $99K | Sell |
|
|||||
|
2017
Q3 | $122K | Buy |
|
|||||
|
2017
Q2 | $6K | Buy |
|
|||||
|
2017
Q1 | $4K | Sell |
|
|||||
|
2016
Q4 | $21K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $120K | Buy |
|